763
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Optimising verbal fluency analysis in neurological patients with dysarthria: examples from Parkinson’s disease and hereditary ataxia

ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 452-463 | Received 30 Nov 2022, Accepted 12 Aug 2023, Published online: 01 Sep 2023

ABSTRACT

Background

Verbal fluency tests (VFTs) are widely used to assess cognitive-linguistic performance in neurological diseases. However, the influence of dysarthria on performance in tests requiring oral responses is unclear in ataxia and Parkinson’s disease.

Objectives

To determine the impact of dysarthria on VFT performance and evaluate the validity and reliability of alternative methods for analyzing VFT data.

Method

Trained raters evaluated dysarthria using VFT recordings in people with ataxia (N = 61) or Parkinson’s disease (PD; N = 69). Total Correct Items scores and qualitative parameters (intrusions, ambiguous verbalizations, perseverations, and interjections) were compared across semantic, phonemic, and alternating fluency tasks. Disease severity was considered as a covariate in the regression model.

Results

VFT dysarthria ratings correlated with the benchmark (ground truth) dysarthria scores derived from a monologue. Ambiguous responses resulting from unclear speech impeded the rater’s ability to determine if a response was correct. Regression analysis indicated that more severe dysarthria ratings predicted diminished scores in all three tasks (semantic fluency, phonemic fluency and alternating fluency) in the ataxia group. The contribution of disease severity to semantic, phonemic and alternating fluency was reduced substantially in the ataxia group after accounting for dysarthria severity in the model in both groups.

Conclusions

Dysarthria severity can be estimated based on speech samples derived from VFT. Dysarthria can lead to lower total correct items and is associated with more ambiguous verbalizations in VFT. Dysarthria severity should be considered when interpreting VFT performance in common movement disorders.

Introduction

Oral-motor or speech deficits (e.g., dysarthria) are common in neurodegenerative diseases (Brendel et al., Citation2013; Kim et al., Citation2011; Magee et al., Citation2019). For cognitive tests that require oral responses, dysarthria can unduly influence performance. Participant responses may be delayed or unintelligible because of a motor speech impairment. Verbal fluency tests (VFTs) are widely used in neurological populations to measure cognitive and linguistic abilities, including semantic searching and executive functions (Barbosa et al., Citation2017; Hoche et al., Citation2018). Participants are asked verbally to recall words starting with the same letter or from specific semantic categories in one minute (Benton & Hamsher, Citation1976).

Performance on VFT is typically rated quantitatively via the number of total correct items (Benton et al., Citation1983) or qualitatively by characterizing responses as clustering, switching, intrusions, or perseverations (Galaverna et al., Citation2016; Troyer et al., Citation1997). These features offer insight into participants’ cognitive abilities in multiple disease groups with adequate validity and reliability, including dementia and multiple sclerosis (De Araujo et al., Citation2011; Delis et al., Citation2004; Henry & Beatty, Citation2006; Jaimes-Bautista et al., Citation2020). Data from VFT in disease groups where motor speech impairment impacts speech rate or clarity may not be accurate representations of verbal ability or executive function.

Dysarthria can manifest in reduced speech rate and imprecise articulation, abnormal nasal resonance and poor voice quality, pitch and loudness control. Motor impairments may also impact patients’ cognitive capacity to perform lexical searching and quick oral responses through cognitive-motor interference, adversely affecting VFT performance (Camicioli et al., Citation1998). An investigation into the competing demands on the performance of motor and cognitive performance is needed.

VFTs are used in neurodegenerative diseases like Parkinson’s disease (PD) and hereditary ataxias to assess verbal fluency despite the potential impact of dysarthria on performance. PD progression leads to changes in speech, voice, cognition and language function (Magee et al., Citation2019). The majority of patients with PD present with hypokinetic dysarthria characterized by soft, harsh voice quality, imprecise articulation and diminished intelligibility (Duffy, Citation2019; Ho et al., Citation1998; Sapir et al., Citation2010). A review study by Sapir (Citation2014) concluded that these symptoms might be accounted for by bradykinesia and hypokinesia secondary to dopaminergic depletion. The link between dysarthria and VFT performance is not well described with earlier work appearing to treat VFT as a cognitive task without regard for the effect motor impairment has on verbal response rates (See ).

Genetically inherited ataxias such as Friedreich’s ataxia (FRDA) and spinocerebellar ataxia lead to incoordination, slower processing, and dysarthria (Corben et al., Citation2017; Folker et al., Citation2010; Harding et al., Citation2016; Vogel et al., Citation2022). Ataxic Dysarthria is a common disease manifestation in hereditary ataxias, including FRDA, spinocerebellar ataxias and cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS; Brendel et al., Citation2013; Schalling & Hartelius, Citation2013; Sidtis et al., Citation2011; Szmulewicz et al., Citation2016). Ataxia dysarthria is accounted for by speech programming deficits associated with impairments of the cerebellum and its input and output circuits (Schalling & Hartelius, Citation2013; Schirinzi et al., Citation2020; Spencer & Slocomb, Citation2007). Most dysarthric patients with ataxia present with vocal instability, speech slowness and impaired voice and articulatory quality (Kent et al., Citation2000; Rusz et al., Citation2019; Spencer & Slocomb, Citation2007). Each ataxia type demonstrates varied impaired neurological pathways and result in slightly different involvement of the speech symptoms (Schalling & Hartelius, Citation2013). For example, spinocerebellar ataxia type 1, 2 and 3 display more extracerebellar lesions associated with more prominent voice symptoms whereas FRDA involves central and peripheral dysfunctions associated with voice, breath and nasality abnormalities (Schalling & Hartelius, Citation2013; Schirinzi et al., Citation2020). In contrast, Spinocerebellar type 6 involves cerebellar nuclei damages associated with more distinct articulatory and timing impairments (Schalling & Hartelius, Citation2013). The link between dysarthria and VFT performance in ataxia is not clear, with some suggesting speech function did not influence VFT and others showing a relationship between the domains (See ). Despite the likelihood that motor impairments influence VFT performance, many protocols in these two populations fail to include dysarthria severity as a covariate when interpreting endpoints (Leggio, Citation2000; Tamura et al., Citation2018).

To overcome these limitations, we analyzed VFT data in two groups where motor speech impairment is common with the aim of disentangling the influence of dysarthria on VFT performance. To achieve this, we 1) investigated the feasibility of determining dysarthria severity from speech samples collected during VFT; and 2) examined whether dysarthric participants with PD and ataxia present with different VFT outcomes in the context of their dysarthria. It is predicted that trained raters can produce dysarthria ratings with adequate validity and reliability based on VFT performance compared to typical tasks (e.g., monologue); that more severe dysarthria predicts poorer VFT performance in the ataxia and PD groups, and when controlling for disease severity, participants with more severe dysarthria demonstrate more diminished VFT scores and more erroneous items compared to those with milder or no dysarthria in the ataxia and PD groups, respectively.

Methods

Participants

One hundred and twenty-nine participants (61 with ataxia, 68 with PD) were recruited for the study (). Participants with ataxia presented with a genetically confirmed ataxia or idiopathic ataxia were recruited from the Department of Neurology, University Hospital Tübingen, Germany and Alfred Health, Melbourne, Australia (Vogel et al., Citation2019). Participants with PD were drawn from a previously published study on PD-related cognitive impairments (Pourzinal et al., Citation2020). Participants with PD who met the UK Brain Bank criteria for idiopathic PD were recruited from movement disorders outpatient neurology clinics in Queensland, Australia to the original study on mild cognitive impairment in PD (PD-MCI), in which de-identified data was shared for this study from our existing database (Gibb & Lees, Citation1988; Pourzinal et al., Citation2020). Dysarthria status was not an inclusion criterion. Individuals with a co-morbid neurological condition (e.g., dementia) were excluded.

Table 1. Demographic and clinical characteristics of participants.

Disease severity

The Part III scores of the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS; Goetz et al., Citation2008) were used to determine the disease severity in the PD group. The MDS-UPDRS is a rating scale utilized to evaluate the severity of motor and non-motor PD symptoms. It consists of four parts: I) non-motor experiences of daily living; II) Motor experiences of daily living; III) motor examination; IV) motor complications. The assessment was conducted by Movement Disorder Society certified assessors. The Hoehn and Yahr scores of participants with PD were also collected. The Scale for Assessment and Rating of Ataxia (SARA) reflected the ataxia group’s disease severity: zero indicates no impairments and 40 indicates the most severe ataxia (Schmitz-Hübsch, Citation2010). It consists of eight items, including gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating hand movement and heel-shin slide (Schmitz-Hübsch, Citation2010). The SARA was conducted by neurologists involved in the primary study (Vogel et al., Citation2019).

Verbal fluency tests

All participants completed semantic, phonemic and alternating verbal fluency tasks (Delis et al., Citation2001). Participants recalled as many words as they could starting with the letter “f” (phonemic) and animals (semantic; Delis et al., Citation2001; Hoche et al., Citation2018). The alternating tasks differed between clinical groups, vegetable and occupation for the ataxia group and fruit and furniture for the PD group. The time limit for each task was 60 seconds. Both disease groups completed all VFTs in English.

For PD participants, individuals were prompted if the subject fails to make a response after any 15-second interval. Individuals were also prompted if they generate three consecutive words that do not start with the designated letter. This prompt was only provided once per trial. For ataxia participants, individuals received responses from the assessor if they had questions however did not receive prompts and clarifying questions throughout the test administration.

Scoring and analysis

Dysarthria ratings

Two groups of trained raters each containing two raters analyzed speech from the VFT tasks. Speech was rated on a 0–4 Likert scale (0 = normal, 1 = subclinical, 2 = mild, 3 = moderate, 4 = severe) across five integral sub-domains of speech production, including articulation, voice quality, resonance, intelligibility, and naturalness (see ; Vogel et al., Citation2019). Articulation, voice quality, and resonance reflected speech production accuracy, vocal fold functioning, and velopharyngeal functioning, respectively (Vogel et al., Citation2019). Intelligibility and naturalness measured the extent to which the speaker can be understood and perceived as natural by listeners, respectively. The average scores between raters were established for all sub-domains (i.e., one participant had five scores for five sub-domains). The highest sub-domain score was selected as the overall dysarthria severity score for each participant because the most severe sub-domain impairment is likely to determine the overall perceived speech quality (see for the rater training procedures). As a comparator to VFT-derived dysarthria scores, participants in the ataxia group were instructed to produce an unprepared monologue for one to two minutes. These monologue samples were rated using the same criteria above by trained raters distinct from those who rated dysarthria from VFT. Intelligibility and naturalness were collected from the monologue samples as overarching summative estimates of participants’ speech.

Total correct items

The Total Correct Items scores in each fluency task were counted. Words with different derivational suffixes (e.g., “functional” and “functioning”) are counted as a single correct item, and proper nouns were discounted (Barbosa et al., Citation2017; Galaverna et al., Citation2016; Rodrigues et al., Citation2015). Homophones were counted if the subject clarified their meanings, and words starting with the /f/ sound rather than the letter “f” were discounted.

Qualitative analysis: Error patterns and fillers

Intrusions, ambiguous verbalizations, perseverations, and interjections were scored across tasks (see ). Intrusions were words that violated instructions. Ambiguous verbalizations were unrecognized words. Perseverations were repeated correct items or intrusions. Interjections were meaningless vocalizations used by participants.

Statistical analysis

The relationship between dysarthria ratings based on VFT and dysarthria ratings based on the monologue task (criterion) was examined via Spearman's correlation in the ataxia group.

Hierarchical linear regressions were used to determine the overall dysarthria severity score contributed to the difference in Total Correct Items scores among participants with different disease severity in the PD and ataxia group, respectively. Education was set as a covariate. This was achieved by utilizing a hierarchical linear regression analysis comprising a pre-arranged order, namely disease severity followed by the years of education followed by dysarthria severity. Age was not included as a covariate to reduce multicollinearity bias because it was correlated with both disease severity and dysarthria.

In addition, because speech impairment is included in both the SARA and MDS-UPDRS Part III scales, a supplemental hierarchical linear regression investigated the relationship between Total Correct Items and dysarthria among different disease severity levels, with speech items omitted from the disease severity measures.

The average of each qualitative outcome measure across three VFT types was calculated (i.e., intrusions, ambiguous verbalizations, perseverations, and interjections). One-way ANOVA with post-hoc Tukey tests was used to compare each parameter across dysarthria severity levels.

The intra-class correlation was calculated to estimate interrater reliability. Intra-class correlation with a two-way random model estimated the absolute agreement of dysarthria ratings by two raters across articulation, voice quality, resonance, intelligibility and naturalness (Koo & Li, Citation2016). The intra-class correlation of resonance in the PD group was replaced by the agreement rate due to the lack of intra-population variation. Statistical analyses were performed using Minitab 19 (Minitab LLC, Center County, Pennsylvania) and Statistical Package for the Social Sciences (25.0; IBM Corp., Armonk, NY).

Results

Dysarthria and total correct items

shows the median and range of dysarthria ratings and the mean of the Total Correct Items score in semantic, phonemic, and alternating fluency from two disease groups. Although this is not the main purpose of this study, higher dysarthria severity (see , p = 0.001**) and a wider dysarthria rating range (see ) were observed in the ataxia group compared to the PD group. The ataxia group and the PD group employed different task instructions in VFTs except for semantic fluency. In semantic fluency, the two groups did not exhibit statistically significant differences (see ; p = 0.437).

Correlation between dysarthria ratings based on VFT and monologue

Dysarthria ratings based on VFT were positively correlated with dysarthria ratings based on the monologue task in two summative speech quality measures, namely intelligibility and naturalness (see ). The Spearman’s ρ between ratings based on VFT by two trained raters and ratings based on monologue by independent raters was 0.715 (p < 0.001, ) and 0.727 (p < 0.001, ) for intelligibility and naturalness, respectively, indicating strong positive correlations.

Figure 1. Spearman’s correlation between VFT dysarthria ratings and monologue dysarthria ratings (intelligibility, naturalness, N = 58) of the ataxia patients.

Figure 1. Spearman’s correlation between VFT dysarthria ratings and monologue dysarthria ratings (intelligibility, naturalness, N = 58) of the ataxia patients.

Impact of dysarthria on quantitative measures: Regression analysis

Ataxia group

summarizes the regression analyses. All Betas reported in were obtained from the final regression model after all independent variables were entered. Dysarthria ratings significantly predicted decreased Total Correct Items score in all three tasks (standardized Beta = −0.445, −0.420 and −0.449 in semantic, phonemic, and alternating fluency, respectively) when the SARA scores were entered before the dysarthria rating. Dysarthria accounted for 15.5% (p = 0.001**, partial correlation = −0.435), 13.8% (p = 0.001**, partial correlation = −0.409) and 15.7% (p = 0.000***, partial correlation = −0.458) of the variance in semantic, phonemic and alternating fluency, respectively. The variance explained by the SARA score remained insignificant in semantic (R square change [ΔR2] = 18%, p = 0.080, partial correlation = −0.230) and phonemic fluency (ΔR2 = 14%, p = 0.177, partial correlation = −0.178). In alternating fluency, the variance accounted for by the SARA score as 24.9% and the contribution of the SARA score was non-significant (p = 0.014, partial correlation = −0.316). The years of education did not predict the Total correct items score in all three tasks.

Table 2. Hierarchical linear regression analysis: the effect of dysarthria on total correct items.

When the speech item was omitted from the SARA score, the regression analysis provided similar results. Dysarthria significantly predicted decreased Total Correct Items scores in all three tasks, and the SARA score without the speech item did not predict Total Correct Items in alternating fluency ().

PD group

Dysarthria ratings did not predict diminished Total Correct Items scores in semantic fluency (standardized Beta = −0.247) and phonemic fluency (standardized Beta = −0.235). Dysarthria accounted for 6.6% (p = 0.021, partial correlation = −0.281), 5.2% (p = 0.040, partial correlation = −0.251) and 2.4% (p = 0.178, partial correlation = −0.167) of the variance in semantic, phonemic and alternating fluency, respectively. In phonemic fluency, the variance explained by the MDS-UPDRS Part III score remained insignificant (ΔR2 = 8.1%, p = 0.185, partial correlation = −0.164). The MDS-UPDRS Part III score did not predict semantic and alternating fluency scores, accounting for 12.4% (p = 0.037, partial correlation = −0.255) and 11% (p = 0.040, partial correlation = −0.251) of the variance, respectively. In phonemic fluency, the years of education significantly predicted increased Total Correct Items (ΔR2 = 10.2%, p = 0.004*, partial correlation = 0.345).

When the speech item was omitted from the MDS-UPDRS Part III score, the regression analysis provided similar results. The years of education significantly predicted increased Total Correct Items in phonemic fluency (). The MDS-UPDRS Part III score (without the speech item) and dysarthria did not predict diminished Total Correct Items in all verbal fluency tasks.

Impact of dysarthria on qualitative measures: Error and filler analysis

shows the results of one-way ANOVA and post-hoc comparisons of intrusions, ambiguous verbalizations, perseverations, and interjections. In the ataxia group, there was a significant main effect of dysarthria on ambiguous verbalizations (F4,60 = 25.00, p < 0.001, η2 = 0.641; see ). Post-hoc comparisons revealed more ambiguous verbalizations in participants with severe dysarthria than those with no dysarthria (adjusted p < 0.001), mild (adjusted p < 0.001) or moderate severity (adjusted p < 0.001). In the PD group, there was no significant effect of dysarthria on all four qualitative measures.

Figure 2. Post-hoc comparisons of dysarthria’s main effect on ambiguous verbalizations, intrusions, interjections and perseverations (mean ± standard error) in semantic, phonemic, and alternating fluency in the ataxia group (N = 61, N = 3, 13, 30, 8, 7 respectively for dysarthria severity 0, 1, 2, 3, 4) and PD group (N = 69, N = 3, 29, 33, 4 respectively for dysarthria severity 0, 1, 2, 3) *p < 0.05; **p < 0.01; ***p < 0.001.

Figure 2. Post-hoc comparisons of dysarthria’s main effect on ambiguous verbalizations, intrusions, interjections and perseverations (mean ± standard error) in semantic, phonemic, and alternating fluency in the ataxia group (N = 61, N = 3, 13, 30, 8, 7 respectively for dysarthria severity 0, 1, 2, 3, 4) and PD group (N = 69, N = 3, 29, 33, 4 respectively for dysarthria severity 0, 1, 2, 3) *p < 0.05; **p < 0.01; ***p < 0.001.

Interrater reliability

The raters exhibited high-to-excellent (0.692–0.938) levels of interrater reliability () on articulation, voice quality, intelligibility and naturalness and fair reliability (0.692) on resonance in the ataxia group.

Table 3. Interrater reliability analysis: Intra-class correlation (ICC) in the ataxia and PD groups across speech parameters.

Discussion

The influence of disease severity on verbal fluency performance decreased in ataxia and PD groups when dysarthria severity was considered. Increased dysarthria severity was associated with worse performance on VFT, largely independent of disease severity. In the ataxia group, dysarthria predicted poorer performance in semantic, phonemic and alternating fluency. Participants with comorbid ataxia and dysarthria presented with increased ambiguous verbalizations, supporting our hypothesis that more severe dysarthria is associated with increased erroneous items and diminished correct items. A secondary aim of the study was to establish criterion validity and interrater reliability in measuring dysarthria severity in VFT. Our data suggest that intelligibility and naturalness ratings derived from VFTs can be accurately acquired when compared to traditional tasks used for rating speech (i.e., connected speech).

Effect of dysarthria on total correct items and qualitative measures

Dysarthria impacted VFT performance, supporting earlier work in the ataxia population (Feng et al., Citation2014; Hoche et al., Citation2018; Lopes et al., Citation2013). The largest impact was observed across all three VFTs in the ataxia group, with no impact in the PD group. Disease severity appeared to have a small effect on VFT performance when dysarthria was considered in the ataxia group. In contrast, in the PD group, performance on the all three fluency tasks were not driven by either disease severity or dysarthria, and performance on the phonemic fluency task was associated with education levels. Severe dysarthria in ataxia participants was associated with more ambiguous verbalizations and diminished Total Correct Items, as items became unintelligible and were considered erroneous in scoring. An increase in ambiguous verbalizations might be linked to a decrease in Total Correct Items. This was not the case for the PD group, which presented with less severe speech disorder overall. Together, these data suggest that judgments of cognitive capacity may be underestimated if based on VFT in speakers with dysarthria.

Task types and ambiguous verbalizations

Performance on VFT appeared to vary by disease group. In the ataxia group, dysarthria had a significant impact on all VFT tasks. An explanation for this impact might be attributed to cognitive-motor interference (CMI), in which comorbid cognitive and motor disturbances can induce difficulties in tasks requiring simultaneous cognitive and motor responses (Barbosa et al., Citation2017). As a result, a VFT that is already affected by participants’ specific cognitive impairments might be disproportionately vulnerable to oral motor impairments. Studies on spinocerebellar ataxia type 1 and Friedreich’s ataxia have delineated greater impairment in phonemic and alternating fluency compared to semantic fluency due to frontal executive dysfunction (Bürk et al., Citation2003; Nóbrega et al., Citation2007). Studies on spinocerebellar ataxia type 6 and multiple system atrophy of the cerebellar type (MSA-C) have reported impaired semantic and phonemic fluency (Bürk et al., Citation2006; Suenaga et al., Citation2008). These findings implied that the execution of these tasks might be more vulnerable in populations with dysarthria and related CMI secondary to cerebellar conditions. A unique finding from the current study is the impact of dysarthria on semantic fluency, despite previous work suggesting semantic fluency remains intact in people with ataxia (Nóbrega et al., Citation2007). Our data suggest that dysarthria might be a driver of poor performance on semantic fluency tasks in this group, as disease severity did not appear to influence outcomes when dysarthria was considered.

VFT dysarthria ratings: Criterion validity and reliability

Trained raters appear to provide equivalent ratings for dysarthria from VFT and connected speech tasks alike. While no identical studies are available for comparison, it appears that dysarthria ratings can reliably be attributed to speakers when raters can identify dysarthric characteristics in single-word utterances, (e.g., distorted articulation, hyper- and hypo-nasality). VFT speech samples appear sufficient to yield summative ratings of intelligibility. However, it is important to note that raters may not have adequate information to perceive speech characteristics such as monoloudness, monopitch, breath support, and resonance as well as functional capacity on single-word samples.

Implications and limitations

These results built on existing evidence of CMI in neurological populations with dysarthria and contributed to a clearer understanding of how CMI could impact patients’ performance in tasks involving verbal responses. Most methodologies do not consider dysarthria as an influencing factor on VFT (e.g., Henry & Crawford, Citation2004; Lopes et al., Citation2013; Rodrigues et al., Citation2015; Tamura et al., Citation2018). Thus, to optimize assessment, when participants present with cognitive impairments and dysarthria, it is prudent for assessors to incorporate non-verbal cognitive measurements and/or account for the impact of dysarthria on performance (e.g., incorporate dysarthria ratings into covariate analysis).

Some key limitations of our protocol relate to disease severity distribution and methods for dysarthria rating validation. It was not clear whether the established criterion validity of VFT dysarthria ratings in the ataxia group could be generalized to the PD group, as comparisons were only made for ataxia. Our cohort did not include individuals with advanced PD or severe dysarthria, and the ataxia group included a cohort of mixed ataxia types, rather than a specific genotype. The VFT instructions were slightly different in the two primary studies, which did not allow for direct comparisons between groups.

Conclusions

Dysarthria appears to influence verbal fluency performance in ataxia and Parkinson’s disease. When dysarthria severity was included as a covariate in predictive models of VFT performance, the impact of disease severity was reduced. We also provide evidence that dysarthria severity can be reliably derived from VFT.

Disclosure of interest

Dr Vogel is the Chief Science Officer of Redenlab Inc. Miss Li is a Project Manager of Redenlab Inc.

Compliance with ethical standards

The present study received institutional ethical approval from the University of Melbourne (1,339,394.2), and University Hospital Tübingen, Germany (Az. 003/2015BO2). The human research ethics committees of the University of Queensland (2,015,001,881) and the Royal Brisbane and Women’s Hospital (HREC/15/QRBW/446) approved the PD-MCI project titled “Markers and Mechanisms of Mild Cognitive Impairment in Parkinson’s disease” with provision for de-identified data sharing under data sharing agreement executed for this study.

Informed consent

Informed consent was obtained from all participants included in the study.

Acknowledgments

We thank all participants of the study, the Royal Brisbane and Women's Hospital Foundation for funding the original PD-MCI project in Queensland, and the core research team of the PD-MCI project including Professor Gerard Byrne, Professor David Copland, Dr Leander Mitchell, A/Prof John O’Sullivan and Professor Katie McMahon. A/Prof Dissanayaka is supported by the National Health and Medical Research Boosting Dementia Research Leadership Fellowship.

Disclosure statement

Dr Vogel is Chief Science Officer of Redenlab Inc. Miss Li is Project Manager of Redenlab Inc.

Additional information

Funding

Dr Vogel received salaried support from the National Health and Medical Research Council, Australia (1082910) and institutional support from The University of Melbourne. A/Prof Dissanayaka was supported by the National Health and Medical Research Boosting Dementia Research Leadership Fellowship(APP1137339). Dr Yang was supported by an Australian Government Research Training Program Scholarship.

References

  • Barbosa, A. F., Voos, M. C., Chen, J., Francato, D. C. V., Souza, C. D. O., Barbosa, E. R., Chien, H. F., & Mansur, L. L. (2017). Cognitive or cognitive-motor executive function tasks? Evaluating verbal fluency measures in people with Parkinson’s disease. BioMed Research International, 2017, 1–7. https://doi.org/10.1155/2017/7893975
  • Benton, A. L., de Hamsher, S. K., & Sivan, A. B. (1983). Multilingual aplasia examination (2nd ed.) ed.). AJA Associates.
  • Benton, A. L., & Hamsher, K. (1976). Multilingual Aphasia examination manual. University of Iowa.
  • Brendel, B., Ackermann, H., Berg, D., Lindig, T., Schölderle, T., Schöls, L., Synofzik, M., & Ziegler, W. (2013). Friedreich ataxia: Dysarthria profile and clinical data. The Cerebellum, 12(4), 475–484. https://doi.org/10.1007/s12311-012-0440-0
  • Bürk, K., Daum, I., & Rüb, U. (2006). Cognitive function in multiple system atrophy of the cerebellar type. Movement Disorders, 21(6), 772–776. https://doi.org/10.1002/mds.20802
  • Bürk, K., Globas, C., Bosch, S., Klockgether, T., Zuhlke, C., Daum, I., & Dichgans, J. (2003). Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol, 250(2), 207–211. https://doi.org/10.1007/s00415-003-0976-5
  • Camicioli, R., Oken, B. S., Sexton, G., Kaye, J. A., & Nutt, J. G. (1998). Verbal fluency task affects Gait in Parkinson’s disease with motor freezing. Journal of Geriatric Psychiatry and Neurology, 11(4), 181–185. https://doi.org/10.1177/089198879901100403
  • Cooper, J. A., Sagar, H. J., Jordan, N., Harvey, N. S., & Sullivan, E. V. (1991). Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain, 114(5), 2095–2122. https://doi.org/10.1093/brain/114.5.2095
  • Corben, L. A., Klopper, F., Stagnitti, M., Georgiou-Karistianis, N., Bradshaw, J. L., Rance, G., & Delatycki, M. B. (2017). Measuring Inhibition and Cognitive Flexibility in Friedreich Ataxia. The Cerebellum, 16(4), 757–763. https://doi.org/10.1007/s12311-017-0848-7
  • De Araujo, N. B., Barca, M. L., Engedal, K., Coutinho, E. S. F., Deslandes, A. C., & Laks, J. (2011). Verbal fluency in Alzheimer’s disease, Parkinson’s disease, and major depression. Clinics, 66(4), 623–627. https://doi.org/10.1590/s1807-59322011000400017
  • Delis, D., Kaplan, E., & Kramer, J. (2001). Delis-Kaplan executive function system. Harcourt Brace & Company.
  • Delis, D., Kramer, J. H., Kaplan, E., & Holdnack, J. (2004). Reliability and validity of the Delis-Kaplan executive function system: An update. Journal of the International Neuropsychological Society, 10(2), 301–303. https://doi.org/10.1017/S1355617704102191
  • Duffy, J. R. (2019). Motor speech disorders e-book: Substrates, differential diagnosis, and management. Elsevier Health Sciences.
  • Feng, L., Chen, D. B., Hou, L., Huang, L. H., Lu, S. Y., Liang, X. L., & Li, X. H. (2014). Cognitive impairment in native Chinese with spinocerebellar ataxia type 3. European Neurology, 71(5–6), 262–270. https://doi.org/10.1159/000357404
  • Folker, J., Murdoch, B., Cahill, L., Delatycki, M., Corben, L., & Vogel, A. (2010). Dysarthria in Friedreich’s Ataxia: A perceptual analysis. Folia Phoniatrica Et Logopaedica, 62(3), 97–103. https://doi.org/10.1159/000287207
  • Galaverna, F., Bueno, A. M., Morra, C. A., Roca, M., & Torralva, T. (2016). Analysis of errors in verbal fluency tasks in patients with chronic schizophrenia. European Journal of Psychiatry, 30(4), 305–320. http://scielo.isciii.es/scielo.php?pid=S0213-61632016000400006&script=sci_arttext&tlng=pt
  • Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 51(6), 745–752. https://doi.org/10.1136/jnnp.51.6.745
  • Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez-Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang, A. E., Lees, A., Leurgans, S., Lewitt, P. A., Nyenhuis, D., … Lapelle, N. (2008). Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129–2170. https://doi.org/10.1002/mds.22340
  • Harding, I. H., Corben, L. A., Storey, E., Egan, G. F., Stagnitti, M. R., Poudel, G. R., Delatycki, M. B., & Georgiou-Karistianis, N. (2016). Fronto-cerebellar dysfunction and dysconnectivity underlying cognition in Friedreich ataxia: The IMAGE-FRDA study. Human Brain Mapping, 37(1), 338–350. https://doi.org/10.1002/hbm.23034
  • Henry, J. D., & Beatty, W. W. (2006). Verbal fluency deficits in multiple sclerosis. Neuropsychologia, 44(7), 1166–1174. https://doi.org/10.1016/j.neuropsychologia.2005.10.006
  • Henry, J. D., & Crawford, J. R. (2004). Verbal fluency deficits in Parkinson’s disease: A meta-analysis. Journal of the International Neuropsychological Society, 10(4), 608–622. https://doi.org/10.1017/s1355617704104141
  • Hoche, F., Guell, X., Vangel, M. G., Sherman, J. C., & Schmahmann, J. D. (2018). The cerebellar cognitive affective/Schmahmann syndrome scale. Brain, 141(1), 248–270. https://doi.org/10.1093/brain/awx317
  • Ho, A. K., Iansek, R., Marigliani, C., Bradshaw, J. L., & Gates, S. (1998). Speech impairment in a large sample of patients with Parkinson’s disease. Behavioural Neurology, 11(3), 131. https://doi.org/10.1155/1999/327643
  • Jaimes-Bautista, A. G., Rodríguez-Camacho, M., Martínez-Juárez, I. E., & Rodríguez-Agudelo, Y. (2020). Quantitative and qualitative analysis of semantic verbal fluency in patients with temporal lobe epilepsy. Neurología (English Edition), 35(1), 1–9. https://doi.org/10.1016/j.nrleng.2019.03.006
  • Kent, R. D., Kent, J. F., Duffy, J. R., Thomas, J. E., Weismer, G., & Stuntebeck, S. (2000). Ataxic dysarthria. Journal of Speech, Language, and Hearing Research, 43(5), 1275–1289. https://doi.org/10.1044/jslhr.4305.1275
  • Kim, Y., Kent, R. D., & Weismer, G. (2011). An acoustic study of the relationships among neurologic disease, dysarthria type, and severity of Dysarthria. Journal of Speech, Language, and Hearing Research, 54(2), 417–429. https://doi.org/10.1044/1092-4388(2010/10-0020)
  • Koo, T. K., & Li, M. Y. (2016). A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine, 15(2), 155–163. https://doi.org/10.1016/j.jcm.2016.02.012
  • Leggio, M. G. (2000). Phonological grouping is specifically affected in cerebellar patients: A verbal fluency study. Journal of Neurology, Neurosurgery & Psychiatry, 69(1), 102–106. https://doi.org/10.1136/jnnp.69.1.102
  • Lopes, T. M., D′Abreu, A., Junior, M. C. F., Yasuda, C. L., Betting, L. E., Samara, A. B., Castellano, G., Somazz, J. C., Balthazar, M. L. F., Lopes-Cendes, I., & Cendes, F. (2013). Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3. Journal of Neurology, 260(9), 2370–2379. https://doi.org/10.1007/s00415-013-6998-8
  • Magee, M., Copland, D., & Vogel, A. P. (2019). Motor speech and non-motor language endophenotypes of Parkinson’s disease. Expert Review of Neurotherapeutics, 19(12), 1191–1200. https://doi.org/10.1080/14737175.2019.1649142
  • Nóbrega, É., Nieto, A., Barroso, J., & Montón, F. (2007). Differential impairment in semantic, phonemic, and action fluency performance in Friedreich’s ataxia: Possible evidence of prefrontal dysfunction. Journal of the International Neuropsychological Society, 13(6), 944–952. https://doi.org/10.1017/S1355617707071202
  • Obeso, I., Casabona, E., Bringas, M. L., Álvarez, L., & Jahanshahi, M. (2012). Semantic and phonemic verbal fluency in Parkinson’s disease: Influence of clinical and demographic variables. Behavioural Neurology, 25(2), 111–118. https://doi.org/10.3233/BEN-2011-0354
  • Pourzinal, D., Yang, J. H. J., Byrne, G. J., O’Sullivan, J. D., Mitchell, L., Mcmahon, K. L., Copland, D. A., & Dissanayaka, N. N. (2020). Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis. Journal of Neurology, 267(11), 3213–3222. https://doi.org/10.1007/s00415-020-09977-z
  • Rodrigues, I. T., Ferreira, J. J., Coelho, M., Rosa, M. M., & Castro-Caldas, A. (2015). Action verbal fluency in Parkinson’s patients. Arquivos de Neuro-Psiquiatria, 73(6), 520–525. https://doi.org/10.1590/0004-282x20150056
  • Rusz, J., Tykalová, T., Salerno, G., Bancone, S., Scarpelli, J., & Pellecchia, M. T. (2019). Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy. Journal of Neurology, 266(6), 1394–1404. https://doi.org/10.1007/s00415-019-09271-7
  • Sapir, S. (2014). Multiple factors are involved in the dysarthria associated with Parkinson’s disease: A review with implications for clinical practice and research. Journal of Speech, Language, and Hearing Research, 57(4), 1330–1343 https://doi.org/10.1044/2014_JSLHR-S-13-0039.
  • Sapir, S., Ramig, L. O., Spielman, J. L., & Fox, C. (2010). Formant Centralization Ratio: A Proposal for a New Acoustic Measure of Dysarthric Speech. Journal of Speech, Language, and Hearing Research, 53(1), 114–125. https://doi.org/10.1044/1092-43882009/08-0184
  • Schalling, E., & Hartelius, L. (2013). Speech in spinocerebellar ataxia. Brain & Language, 127(3), 317–322. https://doi.org/10.1016/j.bandl.2013.10.002
  • Schirinzi, T., Sancesario, A., Bertini, E., Castelli, E., & Vasco, G. (2020). Speech and language disorders in Friedreich Ataxia: Highlights on phenomenology, assessment, and therapy. The Cerebellum, 19(1), 126–130. https://doi.org/10.1007/s12311-019-01084-8
  • Schmitz-Hübsch, T. (2010). Scale for the assessment and rating of ataxia (SARA). In K., Katie, & V., Leonard (Eds.), Encyclopedia of Movement Disorders (pp. 95–99). Elsevier.
  • Sidtis, J. J., Ahn, J. S., Gomez, C., & Sidtis, D. (2011). Speech characteristics associated with three genotypes of ataxia. Journal of Communication Disorders, 44(4), 478–492. https://doi.org/10.1016/j.jcomdis.2011.03.002
  • Spencer, K. A., & Slocomb, D. L. (2007). The neural basis of ataxic dysarthria. The Cerebellum, 6(1), 58–65. https://doi.org/10.1080/14734220601145459
  • Suenaga, M., Kawai, Y., Watanabe, H., Atsuta, N., Ito, M., Tanaka, F., Katsuno, M., Fukatsu, H., Naganawa, S., & Sobue, G. (2008). Cognitive impairment in spinocerebellar ataxia type 6. Journal of Neurology, Neurosurgery & Psychiatry, 79(5), 496–499. https://doi.org/10.1136/jnnp.2007.119883
  • Szmulewicz, D. J., Roberts, L., Mclean, C. A., Macdougall, H. G., Halmagyi, G. M., & Storey, E. (2016). Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Neurology: Clinical Practice, 6(1), 61–68. https://doi.org/10.1212/cpj.0000000000000215
  • Tamura, I., Takei, A., Hamada, S., Soma, H., Nonaka, M., Homma, S., & Moriwaka, F. (2018). Executive dysfunction in patients with spinocerebellar ataxia type 3. Journal of Neurology, 265(7), 1563–1572. https://doi.org/10.1007/s00415-018-8883-y
  • Troyer, A. K., Moscovitch, M., & Winocur, G. (1997). Clustering and switching as two components of verbal fluency: Evidence from younger and older healthy adults. Neuropsychology, 11(1), 138–146. https://doi.org/10.1037/0894-4105.11.1.138
  • Vogel, A. P., Graf, L. H., Magee, M., Schöls, L., Rommel, N., & Synofzik, M. (2022). Home-based biofeedback speech treatment improves dysarthria in repeat-expansion SCAs. Annals of Clinical and Translational Neurology, 9(8), 1310–1315. https://doi.org/10.1002/acn3.51613
  • Vogel, A. P., Stoll, L. H., Oettinger, A., Rommel, N., Kraus, E.-M., Timmann, D., Scott, D., Atay, C., Storey, E., Schöls, L., & Synofzik, M. (2019). Speech treatment improves dysarthria in multisystemic ataxia: A rater-blinded, controlled pilot-study in ARSACS. Journal of Neurology, 266(5), 1260–1266. https://doi.org/10.1007/s00415-019-09258-4

Appendix

Table A1. Work on the impact of dysarthria on VFT performance in individuals with PD or ataxia.

Table A2.

Dysarthria features, severity, and qualitative parameters.

Table A3.

Dysarthria rating training procedure.

Table A4.

Supplemental regression analysis: The effect of dysarthria on total correct items (with speech items omitted from disease severity measures).